Physician profile
Joseph E Yared
NPI 1568728749
$2,319.75
in general payments reported to CMS, 2019-2025
14 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $30.85 · 2021: $54.59 · 2023: $333 · 2024: $1,522 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,338 · Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,338.00 |
| Food and Beverage | $672.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $1,338.00 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $503.28 | 2019-2025 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $98.66 | 2019 | |
| Janssen Scientific Affairs, LLC | $83.53 | 2025 | |
| Astellas Pharma US INC | $57.09 | 2019-2023 | Myrbetriq |
| Janssen Biotech, INC. | $48.34 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $47.22 | 2025 | Gemtesa |
| Boston Scientific Corporation | $30.85 | 2020 | |
| Integra Lifesciences Corporation | $24.13 | 2021 | |
| Endo USA, INC. | $23.18 | 2024 | Xiaflex, Aveed |
| Agiliti Surgical, INC. | $18.98 | 2023 | Sonablate, Trinity |
| Pfizer INC. | $17.15 | 2019 | |
| Ambu INC. | $16.47 | 2021 | |
| Allergan, INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Yared listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.